Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07531043
PHASE3

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

Sponsor: Alcon Research

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.

Official title: A Two-Arm Multicenter Clinical Trial to Investigate Efficacy and Safety of FID123472 Ophthalmic Solution Compared With Vehicle in Adult Subjects With Ocular Redness

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

230

Start Date

2026-10

Completion Date

2027-02

Last Updated

2026-06-10

Healthy Volunteers

No

Interventions

DRUG

Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free

Investigational ophthalmic solution applied topically to the eye in a unit dose preservative free (UDPF) formulation

DRUG

Vehicle

Inactive ingredients of FID 123472 applied topically to the eye as an ophthalmic solution in a unit dose preservative free (UDPF) formulation

Locations (1)

Contact Alcon Call Center for Trial Locations

Fort Worth, Texas, United States